Form 4: GE HealthCare CEO Jan Makela Executes Stock Options and Sells Shares
SEC Form 4 Filing
GE HealthCare's CEO, Jan Makela, exercised employee stock options and sold shares of common stock on May 13 and May 15, 2024.
Summary
- Jan Makela, CEO of Imaging at GE HealthCare Technologies Inc., executed employee stock options and sold shares of common stock.
- On May 13, 2024, Makela exercised options to acquire 20,227 shares at $63.51 per share and sold the same amount at a weighted average price of $81.57.
- On May 15, 2024, Makela exercised options to acquire 8,388 shares at $63.51, 25,472 shares at $75.30, and 33,095 shares at $76.37.
- Also on May 15, 2024, Makela sold 66,955 shares at a weighted average price of $81.54.
- Following these transactions, Makela directly owns 63,348 shares of GE HealthCare common stock and 33,096 derivative securities.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock option exercises and sales. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about executive transactions.
Positives
- The exercise of stock options indicates confidence in the company's future performance, at least at the time the options were granted.
Negatives
- The sale of shares by the CEO could be interpreted negatively by some investors, although it is a common practice after exercising options.
Risks
- Executive stock sales can sometimes create short-term downward pressure on the stock price.
Industry Context
Executive stock option exercises and sales are a common part of executive compensation packages in publicly traded companies. The timing and volume of these transactions are often scrutinized by investors for insights into management's perspective on the company's valuation and future prospects.
Comparison to Industry Standards
- Executive compensation practices, including stock options and sales, are generally benchmarked against peer companies within the healthcare technology industry.
- Companies like Siemens Healthineers and Philips also utilize stock options as part of their executive compensation packages.
- The specific terms and conditions of these options, as well as the frequency and volume of share sales, can vary significantly based on company performance, industry trends, and individual executive agreements.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the potential for short-term price fluctuations.
- The transactions do not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| January 3, 2023 | Consummation of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the 'Spin-Off'). |
| March 2, 2023 | 100% of employee stock options from the conversion of certain equity incentive awards previously granted by General Electric Company ('GE') as a result of the Spin-Off became exercisable. |
| July 1, 2023 | 50% of employee stock options from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off became exercisable. |
| March 1, 2024 | 100% of an employee stock option award with respect to GE HealthCare common stock became exercisable. |
| May 13, 2024 | Jan Makela exercised stock options and sold shares. |
| May 15, 2024 | Jan Makela exercised stock options and sold shares. |
| July 1, 2024 | The remaining 50% of employee stock options from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off will become exercisable. |
| March 2, 2030 | Expiration date of employee stock options. |
| July 1, 2031 | Expiration date of employee stock options. |
| March 1, 2033 | Expiration date of employee stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.